Kyu-Sun Lee, Hyungseop Kim, Sun Hwa Lee, Dong-Ju Choi, Minjae Yoon, Eun-Seok Jeon, Jin-Oh Choi, Jeehoon Kang, Hae-Young Lee, Sung-Ho Jung, Jaewon Oh, Seok-Min Kang, Soo Yong Lee, Min Ho Ju, Jae-Joong Kim, Myoung Soo Kim, Hyun-Jai Cho
The effect of changes in immunosuppressive therapy during the acute phase post-heart transplantation (HTx) on clinical outcomes remains unclear. This study aimed to investigate the effects of changes in immunosuppressive therapy by corticosteroid (CS) weaning and everolimus (EVR) initiation during the first year post-HTx on clinical outcomes. We analyzed 622 recipients registered in the Korean Organ Transplant Registry (KOTRY) between January 2014 and December 2021. The median age at HTx was 56 years (interquartile range [IQR], 45-62), and the median follow-up time was 3...
2024: Transplant International